rs144032672

Variant summary

Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2

The NM_002160.4(TNC):​c.628G>A​(p.Gly210Ser) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00258 in 1,614,244 control chromosomes in the GnomAD database, including 5 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0016 ( 1 hom., cov: 34)
Exomes 𝑓: 0.0027 ( 4 hom. )

Consequence

TNC
NM_002160.4 missense

Scores

4
9
6

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:7

Conservation

PhyloP100: 7.84

Publications

9 publications found
Variant links:
Genes affected
TNC (HGNC:5318): (tenascin C) This gene encodes an extracellular matrix protein with a spatially and temporally restricted tissue distribution. This protein is homohexameric with disulfide-linked subunits, and contains multiple EGF-like and fibronectin type-III domains. It is implicated in guidance of migrating neurons as well as axons during development, synaptic plasticity, and neuronal regeneration. [provided by RefSeq, Jul 2011]
DELEC1 (HGNC:23658): (deleted in esophageal cancer 1) The function of this gene is not known. This gene is located in a region commonly deleted in esophageal squamous cell carcinomas. Gene expression is reduced or absent in these carcinomas and thus this is a candidate tumor suppressor gene for esophageal squamous cell carcinomas. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -16 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.060653).
BP6
Variant 9-115087103-C-T is Benign according to our data. Variant chr9-115087103-C-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 445486.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS2
High AC in GnomAd4 at 244 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TNCNM_002160.4 linkc.628G>A p.Gly210Ser missense_variant Exon 3 of 28 ENST00000350763.9 NP_002151.2 P24821-1Q4LE33B4E1W8

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TNCENST00000350763.9 linkc.628G>A p.Gly210Ser missense_variant Exon 3 of 28 1 NM_002160.4 ENSP00000265131.4 P24821-1

Frequencies

GnomAD3 genomes
AF:
0.00160
AC:
244
AN:
152264
Hom.:
1
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.000434
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00111
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000192
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.000753
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00285
Gnomad OTH
AF:
0.00287
GnomAD2 exomes
AF:
0.00130
AC:
326
AN:
251364
AF XY:
0.00133
show subpopulations
Gnomad AFR exome
AF:
0.000369
Gnomad AMR exome
AF:
0.000578
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.000217
Gnomad FIN exome
AF:
0.000416
Gnomad NFE exome
AF:
0.00233
Gnomad OTH exome
AF:
0.00114
GnomAD4 exome
AF:
0.00269
AC:
3927
AN:
1461862
Hom.:
4
Cov.:
37
AF XY:
0.00261
AC XY:
1899
AN XY:
727232
show subpopulations
African (AFR)
AF:
0.000538
AC:
18
AN:
33480
American (AMR)
AF:
0.000671
AC:
30
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26136
East Asian (EAS)
AF:
0.0000756
AC:
3
AN:
39700
South Asian (SAS)
AF:
0.000603
AC:
52
AN:
86258
European-Finnish (FIN)
AF:
0.000880
AC:
47
AN:
53388
Middle Eastern (MID)
AF:
0.00104
AC:
6
AN:
5768
European-Non Finnish (NFE)
AF:
0.00321
AC:
3570
AN:
1112012
Other (OTH)
AF:
0.00333
AC:
201
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.491
Heterozygous variant carriers
0
272
544
815
1087
1359
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
132
264
396
528
660
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00160
AC:
244
AN:
152382
Hom.:
1
Cov.:
34
AF XY:
0.00146
AC XY:
109
AN XY:
74514
show subpopulations
African (AFR)
AF:
0.000433
AC:
18
AN:
41586
American (AMR)
AF:
0.00111
AC:
17
AN:
15312
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.000193
AC:
1
AN:
5190
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4834
European-Finnish (FIN)
AF:
0.000753
AC:
8
AN:
10630
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00285
AC:
194
AN:
68036
Other (OTH)
AF:
0.00284
AC:
6
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
11
22
34
45
56
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00211
Hom.:
4
Bravo
AF:
0.00180
TwinsUK
AF:
0.00189
AC:
7
ALSPAC
AF:
0.00234
AC:
9
ESP6500AA
AF:
0.000227
AC:
1
ESP6500EA
AF:
0.00291
AC:
25
ExAC
AF:
0.00134
AC:
163
Asia WGS
AF:
0.000577
AC:
2
AN:
3478
EpiCase
AF:
0.00316
EpiControl
AF:
0.00273

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:4
Jun 29, 2017
Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Nov 01, 2023
CeGaT Center for Human Genetics Tuebingen
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

TNC: BP4, BS1, BS2 -

Dec 16, 2020
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 29531218) -

Dec 31, 2019
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
May 24, 2021
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Autosomal dominant nonsyndromic hearing loss 56 Benign:1
Mar 15, 2022
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

TNC-related disorder Benign:1
Oct 23, 2019
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.10
BayesDel_addAF
Benign
-0.090
T
BayesDel_noAF
Uncertain
0.090
CADD
Uncertain
25
DANN
Uncertain
1.0
DEOGEN2
Uncertain
0.79
.;D;.;T;.;.
Eigen
Pathogenic
0.77
Eigen_PC
Pathogenic
0.68
FATHMM_MKL
Pathogenic
0.97
D
LIST_S2
Uncertain
0.94
D;D;D;D;D;.
M_CAP
Benign
0.031
D
MetaRNN
Benign
0.061
T;T;T;T;T;T
MetaSVM
Benign
-0.46
T
MutationAssessor
Pathogenic
3.0
.;M;.;.;M;.
PhyloP100
7.8
PrimateAI
Uncertain
0.59
T
PROVEAN
Uncertain
-3.8
D;D;D;D;D;D
REVEL
Uncertain
0.38
Sift
Uncertain
0.014
D;D;D;D;D;D
Sift4G
Uncertain
0.016
D;D;D;D;D;D
Polyphen
1.0, 1.0
.;D;.;D;.;.
Vest4
0.79
MVP
0.60
MPC
0.64
ClinPred
0.13
T
GERP RS
5.2
Varity_R
0.40
gMVP
0.56
Mutation Taster
=97/3
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs144032672; hg19: chr9-117849382; API